MDM2 emerges as key; Software could expose metabolomic information of other diseases —
A new bioinformatic framework developed by researchers at University of California San Diego School of Medicine has identified key proteins significantly altered at the gene-expression level in biopsied tissue from patients with diabetic kidney disease, a result that may reveal new therapeutic targets. … Read the Full Story from the UC San Diego Newsroom
Dr. Kumar Sharma is lead investigator of the team that published the study report in JCI Insights.Kumar Sharma, MD, is Professor of Medicine in the Division of Nephrology and Hypertension.
He directs the Institute for Metabolomic Medicine and the Center for Renal Translational Medicine at UC San Diego School of Medicine.
